Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| CRMT | 8-K | bearish | 9/10 | Americas Car-Mart reported catastrophic Q1 FY2027 results, with total revenue collapsing 57.3% to $145.8M and a GAAP net | Sep 9, 2026 |
| JFIL | 8-K | neutral | 3/10 | Jubilant Flame International approved a 1-for-100 reverse stock split effective September 9, 2026, reducing outstanding | Sep 9, 2026 |
| HLI | 8-K | neutral | 3/10 | Director Gillian B. Zucker will not stand for reelection at the 2026 Annual Meeting, with no disagreement cited. This is | Sep 9, 2026 |
| UNH | 8-K | neutral | 2/10 | UnitedHealth Group filed an 8-K announcing that senior leaders will present at the Wells Fargo 21st Annual Healthcare Co | Sep 9, 2026 |
| AQMS | 8-K | neutral | 2/10 | Aqua Metals filed an 8-K reporting that its ATM sales agent, The Benchmark Company, LLC, assigned its rights and obligat | Sep 9, 2026 |
| ENB | 8-K | neutral | 3/10 | Enbridge announced a planned CEO succession: Greg Ebel will retire as President and CEO effective December 31, 2026, and | Sep 9, 2026 |
| NTLA | 8-K | bullish | 7/10 | Intellia Therapeutics announced FDA acceptance of its Biologics License Application (BLA) for lonvoguran ziclumeran (lon | Sep 9, 2026 |
| ISCO | 8-K | mixed | 6/10 | International Stem Cell Corporation completed the sale of its wholly-owned subsidiary Lifeline Cell Technology (LCT) to | Sep 9, 2026 |
| GBCS | 8-K | bullish | 7/10 | Black Pearl Equities completed its tender offer for Selectis Health (GBCS) at $5.75/share in cash, acquiring ~90.93% of | Sep 9, 2026 |
| AITX | 8-K | neutral | 2/10 | AITX issued a press release announcing additional orders for two RIO 360 units, one RIO Mini, one ROSA, and four SARA li | Sep 9, 2026 |
| BKR | 8-K | neutral | 5/10 | Baker Hughes CEO Lorenzo Simonelli presented at the Barclays 2026 CEO Energy-Power Conference, providing updated FY2026 | Sep 9, 2026 |
| IRT | 8-K | bullish | 7/10 | Independence Realty Trust (IRT) and Centerspace (CSR) entered into a definitive merger agreement to combine in an all-st | Sep 9, 2026 |
| SYY | 8-K | bullish | 6/10 | Sysco reaffirmed its fiscal 2027 guidance (adjusted EPS growth of 9%-11% to ~$5.02-$5.12, net sales growth of 6%-7% to ~ | Sep 9, 2026 |
| PSTL | 8-K | neutral | 4/10 | Postal Realty Trust closed a $27.75M related-party acquisition of 72 USPS-leased properties, paying $25.75M in cash and | Sep 9, 2026 |
| KFY | 8-K | bullish | 7/10 | Korn Ferry reported Q1 FY'27 fee revenue of $756.5M (+7% YoY) and adjusted diluted EPS of $1.43, beating consensus of $1 | Sep 9, 2026 |
| CNM | 8-K | neutral | 5/10 | Core & Main reported fiscal Q2 2026 results with net sales of $2,145M (+2.5% YoY) and diluted EPS of $0.77 (+10.0% YoY), | Sep 9, 2026 |
| AVAT | 8-K | neutral | 2/10 | Avalanche Treasury Corp expanded its board from three to four directors, appointing Virginia Gambale as a new independen | Sep 9, 2026 |
| JILL | 8-K | bullish | 7/10 | J.Jill reported Q2 FY26 results with net sales of $154.8M (+0.5% YoY), a reversal from the -6% decline in Q1. GAAP EPS o | Sep 9, 2026 |
| CC | 8-K | neutral | 3/10 | Chemours filed an 8-K furnishing its September 2026 investor presentation, which recaps Q2 2026 results, the Pathway to | Sep 9, 2026 |
| ACI | 8-K | neutral | 3/10 | Albertsons appointed Meg Whitman as Executive Chair of the Board, expanding the board from 10 to 11 members. Whitman, fo | Sep 9, 2026 |
| JMKE | 8-K | bearish | 6/10 | Jersey Mike's reported Q2 FY2026 revenue of $208M (+10% YoY), in line with consensus of $208.7M, but GAAP net income fel | Sep 9, 2026 |
| XXI | 8-K | neutral | 2/10 | Twenty One Capital appointed David J. Goldschmidt as an independent director and Audit Committee member effective Septem | Sep 9, 2026 |
| KURA | 8-K | bullish | 6/10 | Kura Oncology formed a wholly owned subsidiary, Caspian Therapeutics, to develop next-generation menin inhibitors for di | Sep 9, 2026 |
| SIG | 8-K | bullish | 7/10 | Signet Jewelers reported Q2 FY2027 adjusted diluted EPS of $2.19, beating consensus of $1.74 by 25.9%, while revenue of | Sep 9, 2026 |
| SUNB | 8-K | bullish | 7/10 | Sunbelt Rentals reported record Q1 FY2027 results with total revenue up 11.2% to $3,115M (above $2.99B consensus), GAAP | Sep 9, 2026 |
| CHWY | 8-K | bullish | 6/10 | Chewy reported fiscal Q2 2026 (Aug 2, 2026) results that were in line with consensus on both revenue ($3.33B vs $3.32B e | Sep 9, 2026 |
| NVCR | 8-K | neutral | 2/10 | Director Timothy Scannell retired from NovoCure's board effective September 2, 2026, after five years of service. The fi | Sep 9, 2026 |
| DXLG | 8-K | mixed | 7/10 | DXLG reported Q2 fiscal 2026 results with a GAAP net income of $0.04 per diluted share, a significant improvement from a | Sep 9, 2026 |
| SAIL | 8-K | bullish | 6/10 | SailPoint reported fiscal Q2 2027 results with total revenue of $309M (+17% YoY), slightly below the $310.3M consensus, | Sep 9, 2026 |
| PPIH | 8-K | bullish | 6/10 | Perma-Pipe International Holdings reported strong Q2 FY2026 results with net sales of $59.6M, up 24.4% YoY, and diluted | Sep 9, 2026 |